_________________
February 17, 2022 | ValGenesis partners with Modis to bring best-in-class digital validation solutions to its clients.
The company, which markets its drugs in over 100 countries, applied sophisticated evaluation criteria that matched vendor capabilities with their demanding business needs. At the end of the process, ValGenesis VLMS was the clear winner.
ValGenesis’ latest customer in Italy develops pharmacological solutions for cardiovascular diseases, oncology, and anti-infectives.
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), is proud to announce its new corporate brand identity and redesigned logo. The new design system better reflects the company’s values and positions it for new levels of growth.
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Steve Reynolds as Chief Revenue Officer. Steve will oversee revenue growth through his leadership of the sales team as well as development of new growth strategies.
ValGenesis appoints Mike Hicks as Chief Technology Officer. "I am incredibly excited to join a clear market leader and to be part of the innovative leadership team at ValGenesis.
ValGenesis, Inc., announced the appointment of Bo Olsen as Head of European Operations. Bo will be in charge of developing business opportunities and expanding ValGenesis's operation in the European region.
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin Potts as Vice President of Marketing, effective August 1, 2021.
One of the top ten global pharmaceutical companies selected ValGenesis’ eLog solution to meet its global needs for the digitization of logbooks.
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin O’Donnell as Chief Financial Officer, effective August 2, 2021.